Company
Kira Pharma
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
A leading developer of anti-complement therapies in China focusing complement-mediated autoimmune & inflammatory diseases and other orphan diseases
Loading relationship preview